1. Home
  2. LI vs DXCM Comparison

LI vs DXCM Comparison

Compare LI & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Li Auto Inc.

LI

Li Auto Inc.

HOLD

Current Price

$16.67

Market Cap

17.5B

ML Signal

HOLD

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$72.78

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LI
DXCM
Founded
2015
1999
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5B
25.9B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
LI
DXCM
Price
$16.67
$72.78
Analyst Decision
Hold
Strong Buy
Analyst Count
9
22
Target Price
$20.46
$86.41
AVG Volume (30 Days)
4.6M
5.1M
Earning Date
03-13-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.75
EPS
0.62
1.80
Revenue
$17,952,966,790.00
$4,515,900,000.00
Revenue This Year
N/A
$17.41
Revenue Next Year
$26.33
$12.73
P/E Ratio
$26.91
$40.55
Revenue Growth
N/A
14.21
52 Week Low
$15.71
$54.11
52 Week High
$33.12
$93.25

Technical Indicators

Market Signals
Indicator
LI
DXCM
Relative Strength Index (RSI) 46.95 64.56
Support Level $15.71 $68.54
Resistance Level $17.28 $75.98
Average True Range (ATR) 0.42 2.80
MACD 0.05 0.33
Stochastic Oscillator 47.04 71.02

Price Performance

Historical Comparison
LI
DXCM

About LI Li Auto Inc.

Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: